discontinuing glp-1 Treatment Associated With Up to 60% Weight Regain, With Brajan Budini GLP-1 Receptor Agonists in Periodontology:
Description
The cardiovascular benefits
This rapid growth aligns with the arrival of rival drug Wegovy in the Indian market, signaling a fierce battle ahead in the obesity and diabetes treatment space
If you see GLP-1/GIP, it is tirzepatide
This was confirmed by their reduction in PHQ-9 score of 17 points and of their GAD-7 score by 7 points, with an associated weight loss of over 11%
In a separate 16-week trial, liraglutide improved hormones in obese men with functional hypogonadism, meaning low testosterone was likely related to obesity
